InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,704.28
(
-0.25%
)
US TECH 100
19,260.80
(
-0.31%
)
Dow Jones
42,122.73
(
0.00%
)
Brent Oil
74.37
(
0.86%
)
Bitcoin
62,884.76
(
-0.70%
)
Post# of 27625
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 80
Posts 24707
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Thursday, 01/04/2018 8:13:12 AM

Thursday, January 04, 2018 8:13:12 AM

Post# of 27625
CLSN - 2.72 Pre-market now at 3.28/3.30

Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up